Journal of Diabetes (Oct 2022)

二甲双胍治疗糖尿病周围神经病变——有益还是有害?

  • Juechun Wei,
  • Yanling Wei,
  • Meiyan Huang,
  • Peng Wang,
  • Shushan Jia

DOI
https://doi.org/10.1111/1753-0407.13310
Journal volume & issue
Vol. 14, no. 10
pp. 658 – 669

Abstract

Read online

Abstract Metformin is a hypoglycemic drug widely used in the treatment of type 2 diabetes. It has been proven to have analgesic and neuroprotective effects. Metformin can reverse pain in rodents, such as diabetic neuropathic pain, neuropathic pain caused by chemotherapy drugs, inflammatory pain and pain caused by surgical incision. In clinical use, however, metformin is associated with reduced plasma vitamin B12 levels, which can further neuropathy. In rodent diabetes models, metformin plays a neuroprotective and analgesic role by activating adenosine monophosphate‐activated protein kinase, clearing methylgloxal, reducing insulin resistance, and neuroinflammation. This paper also summarized the neurological adverse reactions of metformin in diabetic patients. In addition, whether metformin has sexual dimorphism needs further study.

Keywords